Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. - Wikidata - wikimedia - TriplyDB

Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.

Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.

http://www.wikidata.org/entity/Q34581507

about

Drug-eluting bead transarterial chemoembolisation for unresectable hepatocellular carcinoma Drug-eluting bead transarterial chemoembolisation for unresectable hepatocellular carcinoma TIGAR regulates DNA damage and repair through pentosephosphate pathway and Cdk5-ATM pathway Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma Advanced imaging techniques in the therapeutic response of transarterial chemoembolization for hepatocellular carcinoma The Changes of HIF-1α and VEGF Expression After TACE in Patients With Hepatocellular Carcinoma Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future Current and future treatments for hepatocellular carcinoma Hepatocellular carcinoma: Consensus, controversies and future directions. A report from the Canadian Association for the Study of the Liver Hepatocellular Carcinoma Meeting Role of Transcatheter Intra-arterial Therapies for Hepatocellular Carcinoma Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation Interventional therapies for hepatocellular carcinoma Transarterial therapy: an evolving treatment modality of hepatocellular carcinoma Transcatheter embolization therapy in liver cancer: an update of clinical evidences Locoregional drug delivery using image-guided intra-arterial drug eluting bead therapy Transarterial Therapies for Hepatocellular Carcinoma Hepatocellular carcinoma: A comprehensive review Management strategies for hepatocellular carcinoma: old certainties and new realities.Cinnamic Acid Derivatives Enhance the Efficacy of Transarterial Embolization in a Rat Model of Hepatocellular Carcinoma.Imaging and Imaging-Guided Interventions in the Diagnosis and Management of Hepatocellular Carcinoma (HCC)-Review of Evidence.Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today?Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.MRI visible drug eluting magnetic microspheres for transcatheter intra-arterial delivery to liver tumors.Phase I study of miriplatin combined with transarterial chemotherapy using CDDP powder in patients with hepatocellular carcinoma.Continuous administration of sorafenib in combination with transarterial chemoembolization in patients with hepatocellular carcinoma: results of a phase I study.Idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma: results of the IDASPHERE phase I trial.Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China Evaluation of CT vascularization patterns for survival prognosis in patients with hepatocellular carcinoma treated by conventional TACE.A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer.Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesions Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: a randomized controlled trial.Sorafenib and 2,3,5-triiodobenzoic acid-loaded imageable microspheres for transarterial embolization of a liver tumor Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study.Prognostic factors for acute kidney injury following transarterial chemoembolization in patients with hepatocellular carcinoma.A multidisciplinary approach to the management of hepatocellular carcinoma.Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma.Targeting the vasculature in hepatocellular carcinoma treatment: Starving versus normalizing blood supply.Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial.Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting.

P2860

Q24187663-1EDEF9F2-3037-49CA-98FD-ECF183D1F483 Q24202061-4117C530-D21E-4CAC-8972-905F26730FAE Q24337162-B4EB260E-43DA-4F23-9539-717F9D19578D Q24635267-F4EB0781-9E70-465A-AF10-27485B2A2944 Q26745449-5849BACB-6195-4A70-86CB-761B7F528318 Q26764896-082EF408-2FBD-43D3-96E0-F30D76EECBE2 Q26771776-CF26816E-F04A-4E6B-9DF4-7CFEC1F3D8EC Q26801211-614D3BF0-092E-4097-AE31-62B230A7F350 Q26828407-DF001BA3-5FC0-4948-A9B6-BC9E6FE93E25 Q26851627-0CF7DC71-C21B-4844-ACE9-D4ACF3FF5B0B Q26852105-85FA67B9-7A9A-490B-AB51-3569C18D2323 Q26864803-A6543EFF-84C6-42EC-8CDE-27DE012163FE Q26866514-E8833B56-C3D1-422A-B684-66F25175C260 Q27003849-30DA6D88-9A60-4B07-8B02-F5A45E477C71 Q27015918-E69E39C0-71C2-4952-BD3E-431212BD354A Q28072845-86D1366A-4C30-49BD-907A-E142FB735CDF Q28087638-F075929F-C8B2-4A38-A2E7-24A5CD4347F7 Q30252143-24A3DDA6-C00E-45C9-92DD-C542CF75A853 Q30275368-B638F0A7-A0A9-475F-9A27-9789F8FD957B Q30458257-7FE217D3-442B-403A-9660-5461C5109BAD Q30468280-2A9788BC-EF6E-4906-8150-D053013A205E Q30479629-557D8FAA-1E4B-464C-900C-741FC08C1B12 Q30624761-14E08371-29D7-414C-BEB1-2B29F2D7A4D5 Q31096586-6A12D0CC-7256-4CCC-86CE-89DC1671B380 Q33392573-DAC3FB3D-27F8-45C1-9D59-6D93A0F77EF2 Q33414645-467F08F1-3B10-4E09-9FAB-771FD93C4685 Q33590853-56D38E5D-4242-46BD-9AC2-E4EBCD68CD92 Q33620645-C768DB07-9D4E-4087-8690-1CBB02393525 Q33621563-544A23E6-31E8-4465-8014-5AD17EC85B10 Q33631372-5689EC1D-33A5-49CF-91A7-106E5A41EA5E Q33648303-30E41D47-6FC1-4F84-8495-F9513B064CFF Q33660203-E1EE0E06-6F88-4F16-A0A6-ED769FEF2A41 Q33677699-6A3B71D0-7310-477C-B558-7031442A7304 Q33691454-B61BB480-6150-4F76-A420-7DC82C723E5E Q33802797-E9D2BCC9-E9F6-4B36-A4CA-0A0B75031BAF Q33916361-9939000B-870B-422F-B2C8-5D690D443CC8 Q33918062-8ED58596-AB9B-4224-852B-8D889CEC9E15 Q33920350-24D6B254-A009-4E99-A9B0-494415CAA83A Q34045215-A8D8886D-29B0-4BA5-94D5-B3ED1BAC8F95 Q34131801-0D0F4B23-891C-4A76-80DB-C14ECABC48E4

P2860

Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.

http://www.wikidata.org/entity/Q34581507

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Transarterial therapy for hepa ...... cohort and randomized studies.

@ast

Transarterial therapy for hepa ...... cohort and randomized studies.

@en

Transarterial therapy for hepa ...... cohort and randomized studies.

@nl

type

label

Transarterial therapy for hepa ...... cohort and randomized studies.

@ast

Transarterial therapy for hepa ...... cohort and randomized studies.

@en

Transarterial therapy for hepa ...... cohort and randomized studies.

@nl

prefLabel

Transarterial therapy for hepa ...... cohort and randomized studies.

@ast

Transarterial therapy for hepa ...... cohort and randomized studies.

@en

Transarterial therapy for hepa ...... cohort and randomized studies.

@nl

P1433

Q34581507-0E117470-5770-4F57-BBBE-3C5E8ED0EF3C

P1476

Q34581507-B12387F7-C372-4E11-B918-8DD12884C864

P2093

Q34581507-00E70DAB-3A70-474C-B803-61C1A34634EA

Q34581507-4B79E58C-70B2-42EA-9185-A704440E54D8

Q34581507-57C25EAD-9A7B-4433-A2B1-B8B0950368D0

Q34581507-7877A39D-DAD2-4D6A-852C-00941F11A368

Q34581507-815202BC-0FA3-47C9-A0F5-29B28ABFAB97

Q34581507-A595F4FF-1B4A-437F-9AFE-6E3264961519

Q34581507-DB9E74BD-C668-42E5-9E04-D87F895C61C2

Q34581507-E01002CA-5720-488E-8CE0-6B6AD10566BE

P2860

Q34581507-103E1FC0-E8FF-4372-8180-89DD8B6B64CA

Q34581507-1A6A222D-2B8C-4FDF-A13D-6909FC5FFDB7

Q34581507-477D8C92-DB80-4A91-BFE1-91104A074709

Q34581507-71FDEA3C-88BB-466C-A0D1-01AEC57DA369

Q34581507-730D9CFA-8567-4D04-88A2-F3528775EC4B

Q34581507-9BC915B7-C9E1-4B7B-BF79-EFFBA2F25713

Q34581507-CF3D12F7-2D76-4322-9ACD-3EDE2A6F4A06

Q34581507-EF884474-509D-4FA8-9B93-FCD79AC2F8DD

Q34581507-F037AEFA-50F5-4FC1-A6A5-065B24C35FE9

Q34581507-F2E45092-F58B-4EEA-8217-CFF3FB0D6053

P2888

Q34581507-BAFEA36C-7782-47F7-984A-80F38C2221D0

P304

Q34581507-AA3533D1-C2AF-4975-8D51-99BA054F8298

P31

Q34581507-4EB35C9C-CAE8-4DA9-8106-0EF1AA480802

Q34581507-aea9d3b1-f4a3-4c7a-bf6e-eb0215674820

P356

Q34581507-9B8852C4-DF77-4BBF-BCFC-276BDA4ACF66

P433

Q34581507-9D1B3B7B-E44E-4AF5-B50E-F4A85CFC90ED

P478

Q34581507-2E1A9309-7D55-4A06-B8DD-4126F58142F4

P50

Q34581507-0E986DE6-5C3A-4FE7-964D-25F9B5B78A47

Q34581507-9E6C60E7-6139-454B-98FC-3A4A5F2E9762

P577

Q34581507-AF78BE37-41F1-4724-B09E-2FC1B54F95B6

P5875

Q34581507-3F5706E0-08E4-4E49-942B-F5B7483C3D92

P6179

Q34581507-FDD05AAA-14A9-4BC9-BC8B-C1B156FD82E3

P698

Q34581507-D462F156-98ED-485D-A291-EE33AC9C0F27

P356

S00270-006-0062-3

P1433

CardioVascular and Interventional Radiology

P1476

Transarterial therapy for hepa ...... cohort and randomized studies

@en

P2093

Christos Triantos

http://www.w3.org/2001/XMLSchema#string

David W Patch

http://www.w3.org/2001/XMLSchema#string

Evangelos Cholongitas

http://www.w3.org/2001/XMLSchema#string

Laura Marelli

http://www.w3.org/2001/XMLSchema#string

Marco Senzolo

http://www.w3.org/2001/XMLSchema#string

Neil Davies

http://www.w3.org/2001/XMLSchema#string

Rosa Stigliano

http://www.w3.org/2001/XMLSchema#string

Tim Meyer

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence based medicine: what it is and what it isn't

Chemoembolization of hepatic neoplasms: safety, complications, and when to worry.

Outcome of transarterial chemoembolization in patients with inoperable hepatocellular carcinoma eligible for radiofrequency ablation

High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma.

Comparison of transcatheter arterial chemoembolization, laparoscopic radiofrequency ablation, and conservative treatment for decompensated cirrhotic patients with hepatocellular carcinoma.

Bile duct cysts secondary to liver infarcts: report of a case and experimental production by small vessel hepatic artery occlusion.

Embolotherapy: agents, clinical applications, and techniques.

Anatomic and technical skill factor of gastroduodenal complication in post-transarterial embolization for hepatocellular carcinoma: a retrospective study of 280 cases

Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents.

Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis.

P2888

s00270-006-0062-3

P304

6-25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00270-006-0062-3

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Jonathan Tibballs

Andrew K Burroughs

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6694756

http://www.w3.org/2001/XMLSchema#string

P6179

1026344023

http://www.w3.org/2001/XMLSchema#string

P698

17103105

http://www.w3.org/2001/XMLSchema#string